Listed

Alzamend Neuro, Inc.

ALZNNasdaqCIK 1677077HealthcareFiscal year ends Apr 30

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$3.0m, Q1 FY2027
Net income−$3.0m, Q1 FY2027
Alzamend Neuro, Inc., income statement, quarterly
Line itemUnitQ2 FY20242023-10-31Q3 FY20242024-01-31Q4 FY20242024-04-30Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31Q4 FY20252025-04-30Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31Q4 FY20262026-04-30Q1 FY20272026-07-31
Research and development$k1,997Research and development, Q2 FY2024, three months to 2023-10-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure1,909Research and development, Q3 FY2024, three months to 2024-01-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure183Research and development, Q4 FY2024, three months to 2024-04-30$183.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-07-22, accession 0001214659-25-010763. Derived: 12-month figure less the 9-month figure.Report this figure207Research and development, Q1 FY2025, three months to 2024-07-31$206.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure311Research and development, Q2 FY2025, three months to 2024-10-31$311.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure447Research and development, Q3 FY2025, three months to 2025-01-31$447.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure450Research and development, Q4 FY2025, three months to 2025-04-30$450.2k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure1,741Research and development, Q1 FY2026, three months to 2025-07-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure176Research and development, Q2 FY2026, three months to 2025-10-31$176.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure1,279Research and development, Q3 FY2026, three months to 2026-01-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure434Research and development, Q4 FY2026, three months to 2026-04-30$434.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure1,086Research and development, Q1 FY2027, three months to 2026-07-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Operating income$k(2,902)Operating income, Q2 FY2024, three months to 2023-10-31−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure(2,660)Operating income, Q3 FY2024, three months to 2024-01-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure(850)Operating income, Q4 FY2024, three months to 2024-04-30−$850.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-07-22, accession 0001214659-25-010763. Derived: 12-month figure less the 9-month figure.Report this figure(962)Operating income, Q1 FY2025, three months to 2024-07-31−$962.4k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure(1,358)Operating income, Q2 FY2025, three months to 2024-10-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(1,037)Operating income, Q3 FY2025, three months to 2025-01-31−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure(1,139)Operating income, Q4 FY2025, three months to 2025-04-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure(2,700)Operating income, Q1 FY2026, three months to 2025-07-31−$2.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure(998)Operating income, Q2 FY2026, three months to 2025-10-31−$998.1k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(2,198)Operating income, Q3 FY2026, three months to 2026-01-31−$2.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure(2,871)Operating income, Q4 FY2026, three months to 2026-04-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure(3,025)Operating income, Q1 FY2027, three months to 2026-07-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Interest expense$k4.3Interest expense, Q2 FY2024, three months to 2023-10-31$4.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure2.5Interest expense, Q3 FY2024, three months to 2024-01-31$2.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure1.5Interest expense, Q4 FY2024, three months to 2024-04-30$1.5k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-07-22, accession 0001214659-25-010763. Derived: 12-month figure less the 9-month figure.Report this figure12.0Interest expense, Q1 FY2025, three months to 2024-07-31$12.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure3.5Interest expense, Q2 FY2025, three months to 2024-10-31$3.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure2.0Interest expense, Q3 FY2025, three months to 2025-01-31$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure0.5Interest expense, Q4 FY2025, three months to 2025-04-30$509. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure2.5Interest expense, Q1 FY2026, three months to 2025-07-31$2.5k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure2.6Interest expense, Q2 FY2026, three months to 2025-10-31$2.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure1.3Interest expense, Q3 FY2026, three months to 2026-01-31$1.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure0.2Interest expense, Q4 FY2026, three months to 2026-04-30$150. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure2.0Interest expense, Q1 FY2027, three months to 2026-07-31$2.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Net income$k(2,906)Net income, Q2 FY2024, three months to 2023-10-31−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure(2,662)Net income, Q3 FY2024, three months to 2024-01-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure(852)Net income, Q4 FY2024, three months to 2024-04-30−$851.5k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-07-22, accession 0001214659-25-010763. Derived: 12-month figure less the 9-month figure.Report this figure(974)Net income, Q1 FY2025, three months to 2024-07-31−$974.4k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure(1,362)Net income, Q2 FY2025, three months to 2024-10-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(1,039)Net income, Q3 FY2025, three months to 2025-01-31−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure(1,139)Net income, Q4 FY2025, three months to 2025-04-30−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure(2,703)Net income, Q1 FY2026, three months to 2025-07-31−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure(1,001)Net income, Q2 FY2026, three months to 2025-10-31−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(2,199)Net income, Q3 FY2026, three months to 2026-01-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure(2,870)Net income, Q4 FY2026, three months to 2026-04-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure(3,027)Net income, Q1 FY2027, three months to 2026-07-31−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Diluted EPS$ per share(4.43)Diluted EPS, Q2 FY2024, three months to 2023-10-31−$4.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure(3.77)Diluted EPS, Q3 FY2024, three months to 2024-01-31−$3.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figurenot reported(11.42)Diluted EPS, Q1 FY2025, three months to 2024-07-31−$11.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure(3.61)Diluted EPS, Q2 FY2025, three months to 2024-10-31−$3.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(1.75)Diluted EPS, Q3 FY2025, three months to 2025-01-31−$1.75 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figurenot reported(1.28)Diluted EPS, Q1 FY2026, three months to 2025-07-31−$1.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure(0.30)Diluted EPS, Q2 FY2026, three months to 2025-10-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(0.58)Diluted EPS, Q3 FY2026, three months to 2026-01-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figurenot reported(0.68)Diluted EPS, Q1 FY2027, three months to 2026-07-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Basic EPS$ per share(4.43)Basic EPS, Q2 FY2024, three months to 2023-10-31−$4.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure(3.77)Basic EPS, Q3 FY2024, three months to 2024-01-31−$3.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figurenot reported(11.42)Basic EPS, Q1 FY2025, three months to 2024-07-31−$11.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure(3.61)Basic EPS, Q2 FY2025, three months to 2024-10-31−$3.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(1.75)Basic EPS, Q3 FY2025, three months to 2025-01-31−$1.75 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figurenot reported(1.28)Basic EPS, Q1 FY2026, three months to 2025-07-31−$1.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure(0.30)Basic EPS, Q2 FY2026, three months to 2025-10-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure(0.58)Basic EPS, Q3 FY2026, three months to 2026-01-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figurenot reported(0.68)Basic EPS, Q1 FY2027, three months to 2026-07-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure

Balance sheet

Cash and equivalents$7.6m, Q1 FY2027
Shareholders' equity$5.8m, Q1 FY2027
Alzamend Neuro, Inc., balance sheet, quarterly
Line itemUnitQ2 FY20242023-10-31Q3 FY20242024-01-31FY20242024-04-30Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31FY20252025-04-30Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31FY20262026-04-30Q1 FY20272026-07-31
Cash and equivalents$k200Cash and equivalents, Q2 FY2024, at 2023-10-31$200.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-12-15, accession 0001214659-23-016500.Report this figure283Cash and equivalents, Q3 FY2024, at 2024-01-31$282.9k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figure376Cash and equivalents, FY2024, at 2024-04-30$376.0k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-07-22, accession 0001214659-25-010763.Report this figure1,194Cash and equivalents, Q1 FY2025, at 2024-07-31$1.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-09-11, accession 0001214659-24-016346.Report this figure4,093Cash and equivalents, Q2 FY2025, at 2024-10-31$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure3,358Cash and equivalents, Q3 FY2025, at 2025-01-31$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure3,949Cash and equivalents, FY2025, at 2025-04-30$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-07-22, accession 0001214659-26-008832.Report this figure5,621Cash and equivalents, Q1 FY2026, at 2025-07-31$5.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure4,449Cash and equivalents, Q2 FY2026, at 2025-10-31$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure2,713Cash and equivalents, Q3 FY2026, at 2026-01-31$2.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure711Cash and equivalents, FY2026, at 2026-04-30$710.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure7,591Cash and equivalents, Q1 FY2027, at 2026-07-31$7.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Current assets$k782Current assets, Q2 FY2024, at 2023-10-31$781.9k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-12-15, accession 0001214659-23-016500.Report this figure594Current assets, Q3 FY2024, at 2024-01-31$593.6k. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figure455Current assets, FY2024, at 2024-04-30$455.2k. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-07-22, accession 0001214659-25-010763.Report this figure1,416Current assets, Q1 FY2025, at 2024-07-31$1.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-09-11, accession 0001214659-24-016346.Report this figure4,767Current assets, Q2 FY2025, at 2024-10-31$4.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure3,947Current assets, Q3 FY2025, at 2025-01-31$3.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure4,177Current assets, FY2025, at 2025-04-30$4.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-07-22, accession 0001214659-26-008832.Report this figure5,929Current assets, Q1 FY2026, at 2025-07-31$5.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure4,721Current assets, Q2 FY2026, at 2025-10-31$4.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure3,699Current assets, Q3 FY2026, at 2026-01-31$3.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure1,764Current assets, FY2026, at 2026-04-30$1.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure8,255Current assets, Q1 FY2027, at 2026-07-31$8.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Total assets$k984Total assets, Q2 FY2024, at 2023-10-31$983.6k. XBRL concept us-gaap:Assets. 10-Q filed 2023-12-15, accession 0001214659-23-016500.Report this figure783Total assets, Q3 FY2024, at 2024-01-31$782.6k. XBRL concept us-gaap:Assets. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figure632Total assets, FY2024, at 2024-04-30$631.6k. XBRL concept us-gaap:Assets. 10-K filed 2025-07-22, accession 0001214659-25-010763.Report this figure1,670Total assets, Q1 FY2025, at 2024-07-31$1.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-09-11, accession 0001214659-24-016346.Report this figure5,008Total assets, Q2 FY2025, at 2024-10-31$5.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure4,176Total assets, Q3 FY2025, at 2025-01-31$4.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure4,603Total assets, FY2025, at 2025-04-30$4.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-07-22, accession 0001214659-26-008832.Report this figure6,327Total assets, Q1 FY2026, at 2025-07-31$6.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure5,092Total assets, Q2 FY2026, at 2025-10-31$5.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure4,042Total assets, Q3 FY2026, at 2026-01-31$4.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure2,079Total assets, FY2026, at 2026-04-30$2.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure8,542Total assets, Q1 FY2027, at 2026-07-31$8.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Current liabilities$knot reported3,826Current liabilities, Q3 FY2024, at 2024-01-31$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Total liabilities$k3,666Total liabilities, Q2 FY2024, at 2023-10-31$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-12-15, accession 0001214659-23-016500.Report this figure4,569Total liabilities, Q3 FY2024, at 2024-01-31$4.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figure3,226Total liabilities, FY2024, at 2024-04-30$3.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-07-22, accession 0001214659-25-010763.Report this figure2,882Total liabilities, Q1 FY2025, at 2024-07-31$2.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-09-11, accession 0001214659-24-016346.Report this figure1,255Total liabilities, Q2 FY2025, at 2024-10-31$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure726Total liabilities, Q3 FY2025, at 2025-01-31$725.9k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure635Total liabilities, FY2025, at 2025-04-30$634.8k. XBRL concept us-gaap:Liabilities. 10-K filed 2026-07-22, accession 0001214659-26-008832.Report this figure983Total liabilities, Q1 FY2026, at 2025-07-31$983.3k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure717Total liabilities, Q2 FY2026, at 2025-10-31$717.5k. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure1,857Total liabilities, Q3 FY2026, at 2026-01-31$1.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure1,346Total liabilities, FY2026, at 2026-04-30$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure2,739Total liabilities, Q1 FY2027, at 2026-07-31$2.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure
Shareholders' equity$k(2,682)Shareholders' equity, Q2 FY2024, at 2023-10-31−$2.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-12-15, accession 0001214659-23-016500.Report this figure(4,264)Shareholders' equity, Q3 FY2024, at 2024-01-31−$4.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figure(2,594)Shareholders' equity, FY2024, at 2024-04-30−$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure(1,212)Shareholders' equity, Q1 FY2025, at 2024-07-31−$1.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure3,753Shareholders' equity, Q2 FY2025, at 2024-10-31$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure3,450Shareholders' equity, Q3 FY2025, at 2025-01-31$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure3,968Shareholders' equity, FY2025, at 2025-04-30$4.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure5,343Shareholders' equity, Q1 FY2026, at 2025-07-31$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure4,374Shareholders' equity, Q2 FY2026, at 2025-10-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure2,200Shareholders' equity, Q3 FY2026, at 2026-01-31$2.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-07-22, accession 0001214659-26-008832.Report this figure733Shareholders' equity, FY2026, at 2026-04-30$733.2k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure5,803Shareholders' equity, Q1 FY2027, at 2026-07-31$5.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure

Cash flow

Operating cash flow−$1.1m, Q1 FY2027
Alzamend Neuro, Inc., cash flow, quarterly
Line itemUnitQ2 FY20242023-10-31Q3 FY20242024-01-31Q4 FY20242024-04-30Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31Q4 FY20252025-04-30Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31Q4 FY20262026-04-30Q1 FY20272026-07-31
Operating cash flow$k(1,513)Operating cash flow, Q2 FY2024, three months to 2023-10-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-12-11, accession 0001214659-24-020264. Derived: 6-month figure less the 3-month figure.Report this figure(2,032)Operating cash flow, Q3 FY2024, three months to 2024-01-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-03-10, accession 0001214659-25-004123. Derived: 9-month figure less the 6-month figure.Report this figure(1,427)Operating cash flow, Q4 FY2024, three months to 2024-04-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-07-22, accession 0001214659-25-010763. Derived: 12-month figure less the 9-month figure.Report this figure(1,056)Operating cash flow, Q1 FY2025, three months to 2024-07-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure(3,400)Operating cash flow, Q2 FY2025, three months to 2024-10-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-09, accession 0001214659-25-017793. Derived: 6-month figure less the 3-month figure.Report this figure(1,424)Operating cash flow, Q3 FY2025, three months to 2025-01-31−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-11, accession 0001214659-26-003166. Derived: 9-month figure less the 6-month figure.Report this figure(689)Operating cash flow, Q4 FY2025, three months to 2025-04-30−$688.7k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure(2,363)Operating cash flow, Q1 FY2026, three months to 2025-07-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure(1,171)Operating cash flow, Q2 FY2026, three months to 2025-10-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-09, accession 0001214659-25-017793. Derived: 6-month figure less the 3-month figure.Report this figure(1,736)Operating cash flow, Q3 FY2026, three months to 2026-01-31−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-11, accession 0001214659-26-003166. Derived: 9-month figure less the 6-month figure.Report this figure(2,797)Operating cash flow, Q4 FY2026, three months to 2026-04-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-07-22, accession 0001214659-26-008832. Derived: 12-month figure less the 9-month figure.Report this figure(1,139)Operating cash flow, Q1 FY2027, three months to 2026-07-31−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure

Shares

Diluted shares (weighted)4.48m, Q1 FY2027
Alzamend Neuro, Inc., shares, quarterly
Line itemUnitQ2 FY20232022-10-31Q3 FY20232023-01-31Q1 FY20242023-07-31Q2 FY20242023-10-31Q3 FY20242024-01-31Q1 FY20252024-07-31Q2 FY20252024-10-31Q3 FY20252025-01-31Q1 FY20262025-07-31Q2 FY20262025-10-31Q3 FY20262026-01-31Q1 FY20272026-07-31
Diluted shares (weighted)k shares6,499Diluted shares (weighted), Q2 FY2023, three months to 2022-10-316,499,230 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-12-15, accession 0001214659-23-016500.Report this figure6,555Diluted shares (weighted), Q3 FY2023, three months to 2023-01-316,555,078 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-03-25, accession 0001214659-24-005088.Report this figure656Diluted shares (weighted), Q1 FY2024, three months to 2023-07-31656,267 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-09-11, accession 0001214659-24-016346.Report this figure656Diluted shares (weighted), Q2 FY2024, three months to 2023-10-31656,378 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-12-11, accession 0001214659-24-020264.Report this figure705Diluted shares (weighted), Q3 FY2024, three months to 2024-01-31705,432 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-03-10, accession 0001214659-25-004123.Report this figure85.3Diluted shares (weighted), Q1 FY2025, three months to 2024-07-3185,314 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-09-10, accession 0001214659-25-013609.Report this figure392Diluted shares (weighted), Q2 FY2025, three months to 2024-10-31392,411 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure612Diluted shares (weighted), Q3 FY2025, three months to 2025-01-31611,978 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure2,106Diluted shares (weighted), Q1 FY2026, three months to 2025-07-312,106,036 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure3,381Diluted shares (weighted), Q2 FY2026, three months to 2025-10-313,380,968 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-09, accession 0001214659-25-017793.Report this figure3,805Diluted shares (weighted), Q3 FY2026, three months to 2026-01-313,804,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-11, accession 0001214659-26-003166.Report this figure4,479Diluted shares (weighted), Q1 FY2027, three months to 2026-07-314,478,709 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure

Shares outstanding: 4.83mShares outstanding, period not labelled, at 2026-09-104,825,723 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-09-10, accession 0001214659-26-011572.Report this figure at Sep 10, 2026, from the cover of the 10-Q filed Sep 10, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.